![Frontiers | Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience | Surgery Frontiers | Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience | Surgery](https://www.frontiersin.org/files/Articles/318887/fsurg-05-00058-HTML/image_m/fsurg-05-00058-g002.jpg)
Frontiers | Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience | Surgery
![Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer - EClinicalMedicine Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer - EClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/40e26e39-a99d-40c6-95ef-b69a7219f596/gr1_lrg.jpg)
Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer - EClinicalMedicine
![Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.,British Journal of Cancer - X-MOL Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.,British Journal of Cancer - X-MOL](https://xpic.x-mol.com/20190517%2F10.1038_s41416-019-0420-y.jpg)
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.,British Journal of Cancer - X-MOL
![Neoadjuvant chemotherapy in advanced ovarian cancer: optimal patient selection and response evaluation - Cho - Chinese Clinical Oncology Neoadjuvant chemotherapy in advanced ovarian cancer: optimal patient selection and response evaluation - Cho - Chinese Clinical Oncology](https://cdn.amegroups.cn/journals/amepc/files/journals/12/articles/22188/public/22188-PB5-2977-R1.png)
Neoadjuvant chemotherapy in advanced ovarian cancer: optimal patient selection and response evaluation - Cho - Chinese Clinical Oncology
![Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy - European Urology Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4f44f55b-69ad-4cc0-a04c-6d060dec8905/gr1_lrg.jpg)
Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy - European Urology
PLOS ONE: Encapsulating fibrosis following neoadjuvant chemotherapy is correlated with outcomes in patients with pancreatic cancer
![Cancers | Free Full-Text | Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis Cancers | Free Full-Text | Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis](https://www.mdpi.com/cancers/cancers-11-00278/article_deploy/html/images/cancers-11-00278-g002.png)
Cancers | Free Full-Text | Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for mu
![Changes in tumor expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in 21 755 patients from the Japanese breast cancer registry - Annals of Oncology Changes in tumor expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in 21 755 patients from the Japanese breast cancer registry - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/b0f6acb1-c444-447b-8352-2711a1165876/gr1.jpg)
Changes in tumor expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in 21 755 patients from the Japanese breast cancer registry - Annals of Oncology
![PDF) Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - A pooled analysis of individual patient data from eight prospectively randomized controlled trials PDF) Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - A pooled analysis of individual patient data from eight prospectively randomized controlled trials](https://i1.rgstatic.net/publication/323420596_Outcome_after_neoadjuvant_chemotherapy_in_elderly_breast_cancer_patients_-_A_pooled_analysis_of_individual_patient_data_from_eight_prospectively_randomized_controlled_trials/links/5a9551590f7e9ba429717984/largepreview.png)
PDF) Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - A pooled analysis of individual patient data from eight prospectively randomized controlled trials
![Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/26a398a3e7c5c2b5cb9982aeb5c55011b9ac210d-381x300.png?auto=format)
Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions
![Forest plots of studies investigating the association of neoadjuvant... | Download Scientific Diagram Forest plots of studies investigating the association of neoadjuvant... | Download Scientific Diagram](https://www.researchgate.net/profile/Mohammad-Abufaraj/publication/329618634/figure/fig2/AS:704217119461376@1544909853295/Forest-plots-of-studies-investigating-the-association-of-neoadjuvant-chemotherapy-with.png)
Forest plots of studies investigating the association of neoadjuvant... | Download Scientific Diagram
![Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs) - European Journal of Surgical Oncology Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs) - European Journal of Surgical Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e0000e4c-2844-41ef-9fa9-5458bd82ae8f/gr1.jpg)
Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs) - European Journal of Surgical Oncology
![Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma - Journal of Thoracic Oncology Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/87b0c3c9-418f-4e8f-befb-a608bf9e58f0/gr1_lrg.jpg)
Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma - Journal of Thoracic Oncology
PLOS ONE: Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database
![Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer | Semantic Scholar Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/28129c085cec31562cf3d92cf9955b5702995a76/6-Figure1-1.png)
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer | Semantic Scholar
![PDF) Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials PDF) Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials](https://i1.rgstatic.net/publication/279304131_Outcome_after_neoadjuvant_chemotherapy_in_young_breast_cancer_patients_a_pooled_analysis_of_individual_patient_data_from_eight_prospectively_randomized_controlled_trials/links/56af21e308ae28588c62d2a7/largepreview.png)
PDF) Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials
![Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy - Yoo - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy - Yoo - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1138d5cc-0fc2-4cd2-992d-82dd9b8ce24c/ags312253-fig-0002-m.jpg)
Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy - Yoo - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library
![Neoadjuvant chemotherapy in advanced ovarian cancer: optimal patient selection and response evaluation - Cho - Chinese Clinical Oncology Neoadjuvant chemotherapy in advanced ovarian cancer: optimal patient selection and response evaluation - Cho - Chinese Clinical Oncology](https://cdn.amegroups.cn/journals/amepc/files/journals/12/articles/22188/public/22188-PB4-8806-R1.png)
Neoadjuvant chemotherapy in advanced ovarian cancer: optimal patient selection and response evaluation - Cho - Chinese Clinical Oncology
![Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis | BMC Cancer | Full Text Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-5499-2/MediaObjects/12885_2019_5499_Fig3_HTML.png)
Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis | BMC Cancer | Full Text
![Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer - Annals of Oncology Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/45a50c9d-99e0-499f-8d1d-1daff4157247/gr1.jpg)
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer - Annals of Oncology
![Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis - The Journal of Thoracic and Cardiovascular Surgery Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis - The Journal of Thoracic and Cardiovascular Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/31c31b49-1890-4e61-8394-df6753c21acf/gr1.jpg)
Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis - The Journal of Thoracic and Cardiovascular Surgery
![Neoadjuvant chemotherapy for luminal a breast cancer: Factors predictive of histopathologic response and oncologic outcome - The American Journal of Surgery Neoadjuvant chemotherapy for luminal a breast cancer: Factors predictive of histopathologic response and oncologic outcome - The American Journal of Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/568a3c24-97e6-42c1-969d-bd02e68884f0/gr1.jpg)